Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis.

Literature DB >> 27291991

The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis.

Mikhail Fominykh¹, Vasily Shuvaev¹, Irina Martynkevich¹, Lyubov Polushkina¹, Vera Udaleva¹, Kudrat Abdulkadyrov¹.

Abstract

Entities: Chemical Disease Species

Keywords: Ruxolitinib; blast phase; combination treatment regimen; myelofibrosis

Mesh：

Substances：

Year: 2016 PMID： 27291991 DOI： 10.1111/bjh.14162

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

Review 1. Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis.

Authors: Andrew T Kuykendall; Nathan P Horvat; Garima Pandey; Rami Komrokji; Gary W Reuther
Journal: Cancers (Basel) Date: 2020-08-14 Impact factor: 6.639

1 in total